SEMA5B and Alzheimer disease: Among the pathways activated in hiNs treated with CHO-APPV717L compared to CHO-APPWT conditioned medium, SEMA5B regulates the elimination of synaptic connections in cultured hippocampal neurons [48], while EPHA1 is a risk-modifying locus for AD [49,50].